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LIVER TRANSPLANTATION IN THE PRESENCE OF
PORTAL VEIN THROMBOSIS
ABSTRACT
Stieber, A.C., Zetti, G., Todo, S., Tzakis, A.G., Fung, J.J., Marino, I., Casavilla,
A., Selby, R.R. and Starzl, T.E. (1991) The spectrum ofportal vein thrombosis in
liver transplantation. Annals of Surgery; 213:199-206
Thrombosis of the portal vein with or without patency of its tributaries used to be a
contraindication to orthotopic liver transplantation (OLTX) until quite recently.
Rapid progress in the surgical technique of OLTX in the last few years has
demonstrated that most patients with portal vein thrombosis can be safely and
successfully transplanted. Presented here is a series of thirty-four patients with
portal vein thrombosis transplanted at the University of Pittsburgh since 1984. The
various techniques used to treat various forms of thrombosis are described. The
survival rate for this series was 67.6% (23 of 34 patients). Survival was best for
patients who underwent phlebothrombectomy or placement of ajump graft from the
superior mesenteric vein. The survival rate also correlated with the amount of blood
required for transfusion during surgery. Overall it is concluded that a vast majority
of the patients with thrombosis of the portal system can be technically transplanted
and that their survival rate is comparable to that of patients with patient portal vein.
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The authors of the worlds most active liver transplant centre have summarised their
experience of transplantation in recipients with portal vein thrombosis, something
which was long considered to be a specific contra-indication. They review the
treatment options for dealing with such a situation and outline broadly the very
successful conclusions.
Difficulties with the portal vein in the recipient can occur broadly in two
situations. There is firstly, the hypoplastic portal vein in children with longstanding
biliary atreasia which fails to provide adequate perfusion of the implanted graft1.
Although not a true thrombosis, the technical reconstructions of conduits and
grafts are almost invariably needed if adequate flow is to be achieved. But,
secondly, and more commonly, there is the situation in the recipient in whom a
thrombosis of the portal vein has occurred and sometimes addilionally of the
superior mesenteric veins. Faced with that situation, there are probably two prime
options. Firstly, the removal of the thrombus from within the vessels, thrombec-
tomy, has been undertaken and as the authors indicate is usually sucessful,
particularly when a very short segment of portal vein is involved. Indeed, the
authors commendation of thrombectomy as the most appropriate way of dealing
with the situation alludes to the fact that the majority of thrombosis are of relatively
short extent. However, more extended thrombi, particularly when longstanding,
cannot be as easily cleared and then one of the vascular reconstructions are needed.
The standard alternative of venous grafting through the transverse meso-colon to
the superior mesenteric vein, may need to be augmented by more innovative
techniques. Reconstruction to an enlarged coronary vein or indeed, massive gastric
varices have been described,2’3, and the crucial component is the establishment of
adequate portal flow. A flow of between 1 and 1.5 litres a minute is probably
adequate for the newly implanted liver4, which can be particularly vulnerable to
hypoxia and hypoperfusion. It is perhaps worth recording that while hepatic artery
ligation or thrombosis in normal circumstances is relatively well tolerated, in a
transplant patient with a newly implanted graft, thrombosis, of either hepatic artery
or portal vein may lead to rapid failure of the newly implanted graft that is bereft of
collaterals5.
Perhaps an area which does require highlighting is the aditional time this
complex reconstructive procedure adds to the operative time to implant the organ.
Once the graft is in place, the graft warming process begins and normal anastomotic
times of 30-40 minutes are recorded. However, if complex vascular reconstructions
are needed, this period of time can be extended significantly and may lead to
primary dysfunction with an increased risk of graft failure. One way of addressing
this issue is to undertake the reconstruction in the recipient with the conduit placed
to the superior mesenteric vein and splenic vein before the graft liver is implanted,
so that the graft liver can go straight on to the implanted venous conduit1.
Perhaps what is much less clear, is the value of anti-thrombotic agents after such
complex reconstruction procedured. While Aspirin, Dipyridamole, Heparin and
Dextran have all been advocated, the objective evidence that they are of value is
far from clear.
One particular circumstance, however, which does clearly require careful coagu-
lation monitoring is the Budd-Chiari syndrome which, not uncommonly, has
secondary thrombosis in the splenic or portal vein. Under those circumstances not
only does the primary condition, often Polycythemia Rubra Vera, require to beHPB INTERNATIONAL 219
addressed, but subsequent anti-coagulation initially with Heparin and long term
Warfarin will be needed.
In summary, therefore, the authors wide experience of grafting in the presence of
portal vein thrombosis (some 9.7% of transplant recipients) highlights clearly the
technical options in dealing with such an eventuality. That patients with multiple
thrombosis can be grafted, is not in doubt, but the increased technical difficulties
and time involved are a significant additional risk which requires careful evaluation.
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